Today’s top gainers include the company Merck & Co., Inc. (NYSE:MRK) which is in the industry Drug Manufacturers – Major, gaining -1.29% today. In the last week its performance is 1.34%, and 13.19% for the past quarter. Currently, Merck & Co., Inc., MRK has a target price of *TBA, so today’s gain of -1.29% is a significant step towards its target price. The GAP today is therefore -0.68%.
Merck & Co., Inc. (NYSE:MRK), has a market cap of 171857.81, and is based in USA. Insider ownership is at 0.04%, and institutional ownership is 74.90%.
At the current price of 62.15, it has a dividend yield of 2.96%, and its target price is *TBA. This is with a profit margin of 13.00%, and total debt/equity of 0.56. Merck & Co., Inc. (NYSE:MRK) has a P/E of 34.04, as well as a forward P/E of 16.12.
With a current EPS of 1.83, and a forecasted EPS growth for next year at 2.85%,Merck & Co., Inc. (NYSE:MRK) has had a EPS growth for the past five years at 41.50%. For the next five years EPS growth is projected to be 6.27%.
Performance for the year is 29.47%. Since its IPO date on 1/2/1970, the total performance to date is 20.54%.
Volume today for Merck & Co., Inc. (NYSE:MRK), is 6916400, while its average volume is 9707.4. Whilst the total gain today was -1.29%, it did have a day high of -2.18%.
Volatility for this week has been at 1.15%, and 1.36% for the month. The 52-week low for Merck & Co., Inc., MRK has been 33.54%, while the 52-week-high has reached -2.18%.
Looking at its return of investments, which is 6.40%, and its return on assets is 5.20%. Merck & Co., Inc. (NYSE:MRK) has an operating margin of 18.10%. With a sales growth of 0.60% quarter over quarter. Bearing in mind that Merck & Co., Inc., MRK is in the sector Healthcare, its long-term debt/equity is 0.55, and has a current ratio of 1.9 and 1.5 for quick ratio.
So what is the value of Merck & Co., Inc.? Well its PEG is 5.43, and the P/S is 4.36, along with a P/B of 3.97. Meanwhile it has a p/cash of 14.52.